Whether deletion of tumor necrosis factor (TNF) receptor 1 or 2 affects lipopolysaccharide (LPS)-mediated signaling is not understood. In this report, we used macrophages derived from wild type (wt) mice and from mice null for the type 1 receptor (p60 ؊/؊ ), the type 2 receptor (p80 ؊/؊ ), or both (p60 ؊/؊ p80 ؊/؊ ) to investigate the effect of these receptors on LPS-mediated activation of NF-B, mitogen-activated protein kinases, and apoptosis. LPS activated NF-B by 3-4-fold in wt cells but by 9 -10-fold in p60 ؊/؊ , p80 ؊/؊ , and p60 ؊/؊ p80 ؊/؊ macrophages. These results correlated with the I B␣ kinase activation, which is needed for NF-B activation. LPSinduced cyclooxygenase-2 and inducible NO synthase proteins and NO production were maximum in p60 ؊/؊ p80 ؊/؊ macrophages and minimum in wt cells. LPS activated C-Jun N-terminal kinase, p38 MAPK , and extracellular signal-regulated kinase in wt cells, but the levels were much higher in p60 ؊/؊ , p80 ؊/؊ , and p60 ؊/؊ p80 ؊/؊ cells. LPS-induced cytotoxicity, poly(ADP-ribose) polymerase cleavage, and annexin V staining were also highest in p60 ؊/؊ p80 ؊/؊ cells and lowest in wt cells. The difference in LPS signaling was unrelated to the expression of LPS receptors, CD14, or toll-like receptor 4. Overall, our studies indicate that deletion of either of the TNF receptors sensitizes the macrophages to LPS and provide evidence for cross-talk between TNF and LPS signaling.It has been known for decades that Gram-negative bacteria and their component lipopolysaccharides (LPS) 1 have antitumor properties in vivo and that these properties are mediated primarily through production of tumor necrosis factor (TNF) (1, 2). LPS or endotoxin is a glycolipid and is an integral component of the outer membrane of Gram-negative bacteria.LPS mediates a number of biologic manifestations of sepsis, including fever, hypotension, multiple organ failure, shock, and death (3). These effects of endotoxin are believed to result from an uncontrolled production of proinflammatory cytokines produced by cells of the reticuloendothelial system, particularly macrophages. LPS-dependent macrophage activation results in the release of TNF, IL-1, IL-6, IL-8, IL-10, and IL-12.LPS interacts with most cells through CD14, a 55-kDa glycosylphosphatidylinositol-anchored protein expressed on the surface of monocytes and neutrophils (4, 5). The binding of LPS to CD14 is enhanced by the LPS-binding protein present in the serum (5, 6). Mice that lack the CD14 gene show resistance to LPS-induced shock (7). LPS is then transferred to the transmembrane signaling receptor toll-like receptor 4 (TLR4) and its accessory protein MD2 (8 -10). LPS stimulation of human monocytes activates several intracellular signaling pathways that include the I B kinase (IKK)-NF-B pathway (11-15) and three mitogen-activated protein kinase (MAPK) pathways: p42/p44 MAPK /extracellular signal-regulated kinases 1 and 2 (ERK1/2) (16 -21), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) (22), and p38 MAPK (23,24).Both LPS ...